Tocopherols in cancer: An update.

Area of Science:

• Nutritional Science
• Oncology
• Biochemistry

Background:

• Tocopherols, a group of vitamin E compounds, possess antioxidant properties and have been investigated for cancer risk reduction.
• Previous cancer prevention studies predominantly focused on alpha-tocopherol, yielding inconsistent clinical trial results.
• The varying efficacies of different tocopherol forms in cancer prevention remain incompletely understood.

Purpose of the Study:

• To review and synthesize current evidence on the anticancer activities of various tocopherol forms (α, β, δ, γ).
• To compare the cancer-preventive potential of different tocopherols based on clinical, epidemiological, and experimental data.
• To highlight the need for further investigation into specific tocopherol isomers for future intervention strategies.

Main Methods:

• Review of follow-up data from clinical trials involving tocopherols.
• Analysis of recent epidemiological evidence related to tocopherol intake and cancer risk.
• Evaluation of in vitro and in vivo experimental studies investigating tocopherol's anticancer mechanisms.

Main Results:

• Experimental studies indicate that delta-tocopherol (δ-tocopherol) and gamma-tocopherol (γ-tocopherol) exhibit stronger anticancer activities compared to alpha-tocopherol (α-tocopherol).
• A natural tocopherol mixture rich in gamma-tocopherol (γ-TmT) also demonstrated significant anticancer potential.
• Inconsistent results from large-scale clinical trials using α-tocopherol contrast with promising experimental findings for other tocopherol forms.

Conclusions:

• Evidence suggests that δ-tocopherol, γ-tocopherol, and γ-TmT may possess superior anticancer properties over α-tocopherol.
• The findings underscore the importance of differentiating between tocopherol forms in cancer prevention research.
• Further detailed investigations into the distinct anticancer activities of various tocopherols are warranted to inform future clinical interventions.